Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBREXAFUNGERP for Candida infection: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where IBREXAFUNGERP was used for Candida infection.

Most Reported Side Effects for IBREXAFUNGERP

Side Effect Reports % Deaths Hosp.
Drug ineffective 31 24.0% 3 3
Diarrhoea 26 20.2% 0 0
Nausea 22 17.1% 0 0
Recalled product administered 20 15.5% 0 1
Vomiting 13 10.1% 0 2
Therapeutic product effect incomplete 10 7.8% 0 0
Dizziness 9 7.0% 0 2
Product dispensing error 9 7.0% 0 0
Abdominal pain 7 5.4% 0 0
Off label use 7 5.4% 1 1
Abdominal pain upper 6 4.7% 0 0
Rash 6 4.7% 0 0
Condition aggravated 5 3.9% 0 0
Pruritus 5 3.9% 0 0

Other Indications for IBREXAFUNGERP

Product used for unknown indication (53) Vulvovaginal mycotic infection (21) Fungal infection (16) Vulvovaginal candidiasis (9)

Other Drugs Used for Candida infection

FLUCONAZOLE (1,134) AMPHOTERICIN B (502) CASPOFUNGIN (343) MICAFUNGIN (264) VORICONAZOLE (242) NYSTATIN (164) ANIDULAFUNGIN (96) CLOTRIMAZOLE (69) FLUCYTOSINE (57) MEROPENEM (50)

Related Pages

IBREXAFUNGERP Full Profile All Candida infection Drugs IBREXAFUNGERP Demographics IBREXAFUNGERP Timeline